Position in NVO
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$183,610
+$42,858 QoQ
Shares Held
3,830
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,040
of 1,348 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curat Global, LLC holds $5,826,997 across 10 Drug Manufacturers - General names. NVO ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,380 | $1,353,823 | |
| 2 | AMGN |
Amgen Inc
|
3,403 | $1,232,294 | |
| 3 | LLY |
ELI LILLY & Co
|
1,015 | $1,217,421 | |
| 4 | PFE |
Pfizer Inc
|
28,763 | $692,613 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,752 | $610,632 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,088 | $263,797 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
3,830 | $183,610 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,723 | $156,899 |
All Filings in NVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,610 | 3,830 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $140,752 | 3,830 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $194,870 | 3,830 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $212,526 | 3,830 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $264,346 | 3,830 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $265,955 | 3,830 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||